enforcement
FDA Publishes Seven Form 483 Inspection Records
FDA posted seven additional Form 483 inspection records involving drug and medical device establishments, including two Daiichi Sankyo manufacturing facilities in Germany and Japan. Among the newly posted documents is a Form 483 issued following a 7/18/2025 inspection of Daiichi Sankyo Europe GmbH, identified as a drug product